Charles Schwab’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.9M | Sell |
561,159
-38,562
| -6% | -$4.94M | 0.01% | 862 |
|
|
2025
Q1 | $53.1M | Sell |
599,721
-4,676
| -0.8% | -$414K | 0.01% | 1030 |
|
|
2024
Q4 | $52.7M | Buy |
604,397
+7,165
| +1% | +$625K | 0.01% | 1096 |
|
|
2024
Q3 | $55.2M | Buy |
597,232
+50,736
| +9% | +$4.69M | 0.01% | 1059 |
|
|
2024
Q2 | $58.9M | Buy |
546,496
+45,361
| +9% | +$4.89M | 0.01% | 944 |
|
|
2024
Q1 | $47.5M | Buy |
501,135
+25,072
| +5% | +$2.38M | 0.01% | 1079 |
|
|
2023
Q4 | $43.9M | Buy |
476,063
+7,646
| +2% | +$705K | 0.01% | 1073 |
|
|
2023
Q3 | $23.5M | Sell |
468,417
-14,066
| -3% | -$706K | 0.01% | 1399 |
|
|
2023
Q2 | $30.5M | Buy |
482,483
+9,593
| +2% | +$606K | 0.01% | 1200 |
|
|
2023
Q1 | $21.3M | Buy |
472,890
+4,431
| +0.9% | +$199K | 0.01% | 1427 |
|
|
2022
Q4 | $20.5M | Buy |
468,459
+10,750
| +2% | +$471K | 0.01% | 1421 |
|
|
2022
Q3 | $30.2M | Buy |
457,709
+12,491
| +3% | +$823K | 0.01% | 1096 |
|
|
2022
Q2 | $22.5M | Sell |
445,218
-2,631
| -0.6% | -$133K | 0.01% | 1314 |
|
|
2022
Q1 | $28.6M | Buy |
447,849
+9,854
| +2% | +$629K | 0.01% | 1260 |
|
|
2021
Q4 | $46.9M | Sell |
437,995
-27,614
| -6% | -$2.96M | 0.01% | 938 |
|
|
2021
Q3 | $47.9M | Buy |
465,609
+3,616
| +0.8% | +$372K | 0.02% | 903 |
|
|
2021
Q2 | $40.6M | Buy |
461,993
+14,238
| +3% | +$1.25M | 0.01% | 1019 |
|
|
2021
Q1 | $43.5M | Buy |
447,755
+35,381
| +9% | +$3.44M | 0.02% | 940 |
|
|
2020
Q4 | $46.2M | Buy |
412,374
+18,782
| +5% | +$2.11M | 0.02% | 810 |
|
|
2020
Q3 | $36.5M | Buy |
393,592
+590
| +0.2% | +$54.7K | 0.02% | 835 |
|
|
2020
Q2 | $30.7M | Buy |
393,002
+27,647
| +8% | +$2.16M | 0.02% | 880 |
|
|
2020
Q1 | $21.4M | Buy |
365,355
+55,884
| +18% | +$3.27M | 0.01% | 971 |
|
|
2019
Q4 | $24.8M | Buy |
309,471
+5,412
| +2% | +$434K | 0.01% | 1069 |
|
|
2019
Q3 | $22.3M | Buy |
304,059
+18,186
| +6% | +$1.34M | 0.01% | 1064 |
|
|
2019
Q2 | $27M | Buy |
285,873
+40,225
| +16% | +$3.79M | 0.02% | 940 |
|
|
2019
Q1 | $19.7M | Buy |
245,648
+8,673
| +4% | +$694K | 0.01% | 1125 |
|
|
2018
Q4 | $12.8M | Buy |
236,975
+1,172
| +0.5% | +$63.2K | 0.01% | 1282 |
|
|
2018
Q3 | $18.4M | Buy |
235,803
+27,508
| +13% | +$2.15M | 0.01% | 1196 |
|
|
2018
Q2 | $13.2M | Buy |
208,295
+10,042
| +5% | +$637K | 0.01% | 1401 |
|
|
2018
Q1 | $18.2M | Buy |
198,253
+9,933
| +5% | +$911K | 0.01% | 1069 |
|
|
2017
Q4 | $14.2M | Buy |
188,320
+19,485
| +12% | +$1.47M | 0.01% | 1239 |
|
|
2017
Q3 | $11.8M | Buy |
168,835
+13,529
| +9% | +$943K | 0.01% | 1301 |
|
|
2017
Q2 | $7.87M | Buy |
155,306
+42,848
| +38% | +$2.17M | 0.01% | 1517 |
|
|
2017
Q1 | $4.5M | Buy |
112,458
+28,306
| +34% | +$1.13M | ﹤0.01% | 1818 |
|
|
2016
Q4 | $2.36M | Buy |
84,152
+4,736
| +6% | +$133K | ﹤0.01% | 2113 |
|
|
2016
Q3 | $2.36M | Buy |
79,416
+35,593
| +81% | +$1.06M | ﹤0.01% | 2057 |
|
|
2016
Q2 | $888K | Buy |
43,823
+18,320
| +72% | +$371K | ﹤0.01% | 2388 |
|
|
2016
Q1 | $461K | Buy |
25,503
+510
| +2% | +$9.22K | ﹤0.01% | 2605 |
|
|
2015
Q4 | $659K | Buy |
24,993
+650
| +3% | +$17.1K | ﹤0.01% | 2528 |
|
|
2015
Q3 | $520K | Buy |
24,343
+1,709
| +8% | +$36.5K | ﹤0.01% | 2608 |
|
|
2015
Q2 | $600K | Buy |
+22,634
| New | +$600K | ﹤0.01% | 2615 |
|